OrbiMed’s Dermira, Inc. DERM Stock Holding History

OrbiMed’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,031,596	Closed	-$7.42M	–	151
2018 Q4	$7.42M	Hold	1,031,596	–	–	0.14%	93
2018 Q3	$11.2M	Hold	1,031,596	–	–	0.14%	109
2018 Q2	$9.49M	Buy	+1,031,596	New	+$9.62M	0.11%	112
2018 Q1	–	Sell	-1,181,168	Closed	-$32.8M	–	153
2017 Q4	$32.8M	Sell	1,181,168 -237,705	-17%	-$6.3M	0.42%	66
2017 Q3	$38.3M	Hold	1,418,873	–	–	0.37%	72
2017 Q2	$41.3M	Buy	1,418,873 +395,200	+39%	+$12M	0.43%	63
2017 Q1	$34.9M	Buy	1,023,673 +598,073	+141%	+$19.3M	0.4%	62
2016 Q4	$12.9M	Hold	425,600	–	–	0.16%	78
2016 Q3	$14.4M	Buy	+425,600	New	+$13.7M	0.16%	86

OrbiMed's DERM Position: Q1 2019 in Review

OrbiMed sold out of Dermira, Inc. (DERM) in Q1 2019, closing a stake of 1,031,596 shares — an estimated $7.42M sold.

OrbiMed first reported a position in DERM in Q3 2016 and held it in 9 quarters. The position peaked at $41.3M in Q2 2017. 144 funds tracked by Wall St. Rank hold DERM as of Q1 2019.

OrbiMed reported no remaining Dermira, Inc. position as of Q1 2019 after selling out during the quarter.
OrbiMed sold 1,031,596 Dermira, Inc. shares in Q1 2019, an estimated $7.42M.
OrbiMed first reported a position in Dermira, Inc. in Q3 2016 and held it in 9 quarters.
OrbiMed's Dermira, Inc. position peaked at $41.3M in Q2 2017.
144 funds tracked by Wall St. Rank held Dermira, Inc. as of Q1 2019.

Based on OrbiMed's 13F filing for Q1 2019, filed 15 May 2019.